SCHEMBL16355367

SCHEMBL16355367

c1cc(-c2ccncc2)cc(-n2nc3ccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)cc3n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.41
MAPK9 P45984 9/20 0.38
MAPK10 P53779 9/20 0.38
MAPK8 P45983 3/20 0.38
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
PIK3CA P42336 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 2/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
APAF1 O14727 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30911080 0.91 GRM5 (0.44) GRM5PIK3CAKDM4EALDH1A1MAPT
SCHEMBL30911081 0.91 GRM5 (0.44) GRM5PIK3CAKDM4EALDH1A1MAPT
SCHEMBL16355316 0.91 MAPK10 (0.42) MAPK9MAPK10MAPK8KDM4EALDH1A1
SCHEMBL15949810 0.91 GRM5 (0.44) GRM5PIK3CAKDM4EALDH1A1MAPT
SCHEMBL16355344 0.90 GRM5 (0.43) GRM5PIK3CAKDM4EALDH1A1MAPT
SCHEMBL16355358 0.89 GRM5 (0.44) GRM5PIK3CAKDM4EALDH1A1MAPT
SCHEMBL16355306 0.89 GRM5 (0.39) GRM5PIK3CAKDM4EALDH1A1MAPT
SCHEMBL30911078 0.89 CYP11B2 (0.54) GRM5CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL15949847 0.89 CYP11B2 (0.54) GRM5CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL16355349 0.89 MAPK10 (0.39) MAPK9MAPK10MAPK8CYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10593884-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2020-03-17 US disclosed
US-20180006235-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2018-01-04 US disclosed
US-20170346009-A1 ORGANIC ELECTROLUMINESCENT DEVICE SFC CO., LTD. (KR) 2017-11-30 US disclosed
US-20170346009-A1 ORGANIC ELECTROLUMINESCENT DEVICE SFC CO., LTD. (KR) 2017-11-30 US disclosed
US-9123897-B2 Benzotriazole derivatives and organic electroluminescent devices using the derivatives HODOGAYA CHEMICAL CO., LTD. (JP) 2015-09-01 US disclosed
US-9123897-B2 Benzotriazole derivatives and organic electroluminescent devices using the derivatives HODOGAYA CHEMICAL CO., LTD. (JP) 2015-09-01 US disclosed
US-20140374721-A1 NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES HODOGAYA CHEMICAL CO., LTD (JP) 2014-12-25 US disclosed
US-20140374721-A1 NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES HODOGAYA CHEMICAL CO., LTD (JP) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10593884-B2 Organic electroluminescent device AHR, SLC18A1, KCNH1 GRM5 2841/4885MAPK9 679/4885MAPK10 710/4885
US-20180006235-A1 ORGANIC ELECTROLUMINESCENT DEVICE AHR, SLC18A1, KCNH1 GRM5 2841/4885MAPK9 679/4885MAPK10 710/4885
US-20170346009-A1 ORGANIC ELECTROLUMINESCENT DEVICE AHR, SLC18A1, ARNT GRM5 2669/4885MAPK9 528/4885MAPK10 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.